A physiologically-based pharmacokinetic (PBPK) model of hydroxychloroquine

被引：0
|
作者：
Collins, Keagan P.
Jackson, Kristen M.
Gustafson, Daniel L.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1503
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1503
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL OF ETHANOL IN THE MOUSE
    PASTINO, GM
    SULTATOS, LG
    FLYNN, EJ
    FASEB JOURNAL, 1994, 8 (05): : A952 - A952
  • [22] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL FOR PREDICTION OF PLASMA AND LUNG CONCENTRATIONS AFTER ADMINISTRATION OF CEFTAZIDIME.
    Zhou, D.
    Li, J.
    Xu, H.
    Al-Huniti, N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S88 - S88
  • [23] A Physiologically-Based Pharmacokinetic (PBPK) Model to Explore ALX-0171 PK in Infants Following Inhalation
    Germani, Massimiliano
    Niederalt, Christoph
    Kanacher, Tobias
    Stohr, Thomas
    Detalle, Laurent
    Wendl, Thomas
    Sargentini, Laura
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S98 - S99
  • [24] Physiologically-based pharmacokinetic modeling of enantioselective hydroxychloroquine kinetics and impact of genetic polymorphisms
    Ribeiro, Gabriella de Souza Gomes
    Pippa, Leandro Francisco
    Moreira, Fernanda de Lima
    de Moraes, Natalia Valadares
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2025, 61
  • [25] Determination of the rat tissue partitioning of endotoxin in vitro for physiologically-based pharmacokinetic (PBPK) modeling
    Ross, IA
    Sapienza, PP
    Hanes, DE
    Johnson, W
    Kim, CS
    JOURNAL OF APPLIED TOXICOLOGY, 2004, 24 (03) : 177 - 181
  • [26] PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL TO CHARACTERIZE ORGAN DISTRIBUTION OF BACTERIOPHAGE (PHAGE) IN PRECLINICAL MOUSE STUDIES.
    Hanafin, P.
    Parambi, R.
    Nang, S.
    Lin, Y.
    Wang, J.
    Chen, K.
    Chang, R. Yoon Kyung
    Chan, H.
    Li, J.
    Rao, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S23 - S23
  • [27] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL FOR SIMULATION OF NALOXEGOL PHARMACOKINETICS AND DRUG-DRUG INTERACTION (DDI) POTENTIAL
    Zhou, D.
    Bui, K.
    Sostek, M.
    Al-Huniti, N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S53 - S53
  • [28] Bayesian evaluation of a physiologically-based pharmacokinetic (PBPK) model of long-term kinetics of metal nanoparticles in rats
    Sweeney, Lisa M.
    MacCalman, Laura
    Haber, Lynne T.
    Kuempel, Eileen D.
    Lang Tran, C.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2015, 73 (01) : 151 - 163
  • [29] Utility of Physiologically-Based Pharmacokinetic Model (PBPK) for Prediction of Effects of Renal Impairment: A Learn-Confirm Paradigm
    Xu, Christine
    Kanamaluru, Vanaja
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S92 - S92
  • [30] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR FLUORIDE UPTAKE BY BONE
    RAO, HV
    BELILES, RP
    WHITFORD, GM
    TURNER, CH
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1995, 22 (01) : 30 - 42
12345